Chart 1. Previous studies on NSM for local recurrence after BCS.
Authors (year) | Number of patients | Complication rates | Recurrence rates | Survival | Follow-up (months) |
---|---|---|---|---|---|
Cordeiro et al. (2012) 14 | 121 patients who underwent NSM after recurrence + RT; 1.578 patients who underwent NSM for early cancer |
Flap necrosis: 18% x 7.7%; infection: 8.3% x 4.8%; hematoma: 0.8% x 1.8% |
NA | NA | NA |
Lam et al. (2015) 15 | 22 | Seroma: 13.6%; bleeding: 45.%; delayed wound healing: 4.5%; infection: 4.5% |
LR: 2 | NA | NA |
Murphy et al. (2017) 13 | 21 | Postoperative, requiring intervention: 2; flap necrosis: 1; seroma: 2 |
0% | 100% | Median: 14.6 |
Lee et al. (2019) 12 | 18 patients who underwent NSM after recurrence; 127 patients who underwent NSM for early cancer |
Infecion: 5.6% x 3.9%; nipple necrosis: 11.1% x 17.3% |
LR: 5.6% x 3.1% Metastasis: 0% x 5.5% Contralateral BC: 5.6% x 0.8% |
100% x 97.6% | Mean: 45.5 × 45.3 |
Abbreviations: BCS, breast-conserving surgery; NA, not applicable; NSM, nipple-sparing mastectomy; RT, radiotherapy; BC, breast cancer; LR, local recurrence.